Surfactant protein D is expressed and modulates inflammatory responses in human coronary artery smooth muscle cells

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 294, Issue 5, 2008, Pages

  Snyder, Gary D ^a   Oberley Deegan, Rebecca E ^a   Goss, Kelli L ^a   Romig Martin, Sara A ^a   Stoll, Lynn L ^a   Snyder, Jeanne M ^a   Weintraub, Neal L ^a,b,c  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Chlamydia pneumoniae; Inflammation; Innate immunity; Interleukin 8

Indexed keywords

INTERLEUKIN 8; SURFACTANT PROTEIN D; LIPOPOLYSACCHARIDE; MESSENGER RNA; RECOMBINANT PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CHLAMYDOPHILA PNEUMONIAE; CORONARY ARTERY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; ENDOTHELIUM CELL; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; INFLAMMATION; INNATE IMMUNITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SMOOTH MUSCLE FIBER; CELL CULTURE; CORONARY BLOOD VESSEL; DRUG EFFECT; GENETIC TRANSDUCTION; GENETICS; IMMUNOLOGY; METABOLISM; PATHOGENICITY; PHAGOCYTOSIS; SIGNAL TRANSDUCTION; TIME; VASCULAR SMOOTH MUSCLE;

CELLS, CULTURED; CHLAMYDOPHILA PNEUMONIAE; CORONARY VESSELS; ENDOTHELIAL CELLS; HUMANS; IMMUNITY, NATURAL; INFLAMMATION; INTERLEUKIN-8; LIPOPOLYSACCHARIDES; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; PHAGOCYTOSIS; PULMONARY SURFACTANT-ASSOCIATED PROTEIN D; RECOMBINANT PROTEINS; RNA, MESSENGER; SIGNAL TRANSDUCTION; TIME FACTORS; TRANSDUCTION, GENETIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 44949214913     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.91529.2007     Document Type: Article

References (41)

1. Akashi S, Nagai Y, Ogata H, Oikawa M, Fukase K, Kusumoto S, Kawasaki K, Nishijima M, Hayashi S, Kimoto M, Miyake K. Human MD-2 confers on mouse Toll-like receptor 4 species-specific lipopolysaccharide recognition. Int Immunol 13: 1595-1599, 2001.
2. Akiyama J, Hoffman A, Brown C, Allen L, Edmondson J, Poulain F, Hawgood S. Tissue distribution of surfactant proteins A and D in the mouse. J Histochem Cytochem 50: 993-996, 2002.
3. Anderson RD, Haskell RE, Xia H, Roessler BJ, Davidson BL. A simple method for the rapid generation of recombinant adenovirus vectors. Gene Ther 7: 1034-1038, 2000.
4. Antal-Szalmas P. Evaluation of CD14 in host defense. Eur J Clin Invest 30: 167-179, 2000.
5. Beutler B, Milsark IW, Cerami AC. Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin. Science 229: 869-871, 1985.
6. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254, 1976.
7. Chaby R, Garcia-Verdugo I, Espinassous Q, Augusto LA. Interactions between LPS and lung surfactant proteins. J Endotoxin Res 11: 181-185, 2005.
8. Choi HC, Lee KY. CD14 glycoprotein expressed in vascular smooth muscle cells. J Pharm Sci 95: 65-70, 2004.
9. Crouch EC. Surfactant protein-D and pulmonary host defense. Respir Res 1: 93-108, 2000.
10. Denning GM, Wollenweber LA, Railsback MA, Cox CD, Stoll LL, Britigan BE. Pseudomonas pyocyanin increases interleukin-8 expression by human airway epithelial cells. Infect Immun 66: 5777-5784, 1998.
11. Gardai SJ, Xiao YQ, Dickinson M, Nick JA, Voelker DR, Greene KE, Henson PM. By binding SIRPalpha or calreticulin/CD91, lung collectins act as dual function surveillance molecules to suppress or enhance inflammation. Cell 115: 13-23, 2003.
12. Gerszten RE, Garcia-Zepeda EA, Lim YC, Yoshida M, Hing HA, Gimbrone MAJ, Luster AD, Luscinskas FW, Rosenzweig A. MCP-1 and IL-8 trigger firm adhesion of monocytes to vascular endothelium under flow conditions. Nature 398: 718-723, 1999.
13. Hajjar AM, Ernst RK, Tsai JH, Wilson CB, Miller SI. Human Toll-like receptor 4 recognizes host-specific LPS modifications. Nat Immun 3: 354-359, 2002.
14. Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 352: 1685-1695, 2005.
15. Holmskov U, Mollenhauer J, Madsen J, Vitved L, Gronlund J, Tornoe I, Kliem A, Reid KB, Poustka A, Skjodt K. Cloning of gp-340, a putative opsonin receptor for lung surfactant protein D. Proc Natl Acad Sci USA 96: 10794-10799, 1999.
16. Holmskov U, Thiel S, Jensenius JC. Collections and ficolins: humoral lectins of the innate immune defense. Annu Rev Immunol 21: 547-578, 2003.
17. Kawasaki K, Gomi K, Nishijima M. Cutting edge: Gln22 of mouse MD-2 is essential for species-specific lipopolysaccharide mimetic action of taxol. J Immunol 166: 11-14, 2001.
18. Kol A, Bourcier T, Lichtman AH, Libby P. Chlamydial and human heat shock protein 60s activate human vascular endothelium, smooth muscle cells, and macrophages. J Clin Invest 103: 571-577, 1999.
19. Kuan SF, Rust K, Crouch E. Interactions of surfactant protein D with bacterial lipopolysaccharides. Surfactant protein D is an Escherichia coli-binding protein in bronchoalveolar lavage. J Clin Invest 90: 97-106, 1992.
20. Leth-Larsen R, Floridon C, Nielsen O, Holmskov U. Surfactant protein D in the female genital tract. Mol Hum Reprod 10: 149-154, 2004.
21. Lu J, Willis AC, Reid KB. Purification, characterization and cDNA cloning of human lung surfactant protein D. Biochem J 284: 795-802, 1992.
22. Madsen J, Tornoe I, Nielsen O, Koch C, Steinhilber W, Holmskov U. Expression and localization of lung surfactant protein A in human tissues. Am J Respir Cell Mol Biol 29: 591-597, 2003.
23. McCormack FX, Gibbons R, Ward SR, Kuzmenko A, Wu H, Deepe GS Jr. Macrophage-independent fungicidal action of the pulmonary collectins. J Biol Chem 278: 36250-36256, 2003.
24. Mestas J, Hughes CC. Of mice and not men: differences between mouse and human immunology. J Immunol 172: 2731-2738, 2004.
25. Muller JM, Ziegler-Heitbrock HW, Baeuerle PA. Nuclear factor kappa B, a mediator of lipopolysaccharide effects. Immunobiology 187: 233-256, 1993.
26. Oberley RE, Ault KA, Neff TL, Khubchandani KR, Crouch EC, Snyder JM. Surfactant proteins A and D enhance the phagocytosis of Chlamydia into THP-1 cells. Am J Physiol Lung Cell Mol Physiol 287: L296-L306, 2004.
27. Oberley RE, Goss KL, Ault KA, Crouch EC, Snyder JM. Surfactant protein D is present in human female reproductive tract and inhibits Chlamydia trachomatis infection. Mol Human Reprod 10: 861-870, 2004.
28. O'Riordan DM, Standing JE, Kwon KY, Chang D, Crouch EC, Limper AH. Surfactant protein D interacts with Pneumocystis carinii and mediates organism adherence to alveolar macrophages. J Clin Invest 95: 2699-2710, 1995.
29. Persson A, Chang D, Rust K, Moxley M, Longmore W, Crouch E. Purification and biochemical characterization of CP4 (SP-D), a collagenous surfactant-associated protein. Biochemistry 28: 6361-6367, 1989.
30. Rice JB, Stoll LL, Li WG, Denning GM, Weydert J, Charipar E, Richenbacher WE, Miller FJ Jr, Weintraub NL. Low-level endotoxin induces potent inflammatory activation of human blood vessels: inhibition by statins. Arterioscler Thromb Vasc Biol 23: 1576-1582, 2003.
31. Sano H, Chiba H, Iwaki D, Sohma H, Voelker DR, Kuroki Y. Surfactant proteins A and D bind CD14 by different mechanisms. J Biol Chem 275: 22442-22451, 2000.
32. Sano H, Kuroki Y. The lung collectins, SP-A and SP-D, modulate pulmonary innate immunity. Mol Immunol 42: 279-287, 2005.
33. Sorensen GL, Madsen J, Kejling K, Tornoe I, Nielsen O, Townsend P, Poulain F, Nielsen CH, Reid KBM, Hawgood S, Falk E, Holmskov U. Surfactant protein D is proatherogenic in mice. Am J Physiol Heart Circ Physiol 290: H2286-H2294, 2006.
34. Stahlman MT, Gray ME, Hull WM, Whitsett JA. Immunolocalization of surfactant protein-D (SP-D) in human fetal, newborn, and adult tissues. J Histochem Cytochem 50: 651-660, 2002.
35. Stoll LL, Denning GM, Li WG, Rice JB, Harrelson AL, Romig SA, Gunnlaugsson ST, Miller FJ Jr, Weintraub NL. Regulation of endotoxin-induced proinflammatory activation in human coronary artery cells: expression of functional membrane-bound CD14 by human coronary artery smooth muscle cells. J Immunol 173: 1336-1343, 2004.
36. Takeda K, Akira S. TLR signaling pathways. Semin Immunol 16: 3-9, 2004.
37. Wiedermann CJ, Keith S, Dunzendorfer S, Schratzberger P, Egger G, Oberhollenzer F, Willeit J. Association of endotoxemia with carotid atherosclerosis and cardiovascular disease: prospective results from the Bruneck study. J Am Coll Cardiol 34: 1975-1981, 1999.
38. Wert SE, Yoshida M, LeVine AM, Ikegami M, Jones T, Ross GF, Fisher JH, Korfhagen TR, Whittsett JA. Increased metalloproteinase activity, oxidant production and emphysema in surfactant D gene-inactivated mice. Proc Natl Acad Sci USA 97: 5972-5977, 2000.
39. Yang X, Coriolan D, Murthy V, Schultz K, Golenbock DT, Beasley D. Proinflammatory phenotype of vascular smooth muscle cells: role of efficient Toll-like receptor 4 signaling. Am J Physiol Heart Circ Physiol 289: H1069-H1076, 2005.
40. Yoshida M, Korfhagen TR, Whitsett JA. Surfactant protein D regulates NF-kappa B and matrix metalloproteinase production in alveolar macrophages via oxidant-sensitive pathways. J Immunol 166: 7514-7519, 2001.
41. Yuan XJ, Goldman WF, Tod ML, Rubin LJ, Blaustein MP. Ionic currents in rat pulmonary and mesenteric arterial myocytes in primary culture and subculture. Am J Physiol Lung Cell Mol Physiol 264: L107-L115, 1993.